LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,131,583 | -14.2% | 352,621 | +3.2% | 0.00% | 0.0% |
| Q2 2023 | $24,630,297 | +5.7% | 341,613 | +7.8% | 0.00% | 0.0% |
| Q1 2023 | $23,303,734 | +115931.3% | 316,799 | +5.4% | 0.00% | 0.0% |
| Q4 2022 | $20,084 | -99.9% | 300,670 | +3.6% | 0.00% | -25.0% |
| Q3 2022 | $24,981,000 | -3.7% | 290,110 | -0.2% | 0.00% | 0.0% |
| Q2 2022 | $25,938,000 | -23.3% | 290,725 | -3.3% | 0.00% | 0.0% |
| Q1 2022 | $33,814,000 | -23.1% | 300,597 | +5.6% | 0.00% | -20.0% |
| Q4 2021 | $43,969,000 | +14.3% | 284,663 | +3.1% | 0.01% | 0.0% |
| Q3 2021 | $38,454,000 | +5.6% | 276,015 | -0.6% | 0.01% | 0.0% |
| Q2 2021 | $36,413,000 | -9.1% | 277,560 | +5.6% | 0.01% | -16.7% |
| Q1 2021 | $40,075,000 | +72.4% | 262,876 | +12.4% | 0.01% | +50.0% |
| Q4 2020 | $23,252,000 | +5.2% | 233,807 | +0.9% | 0.00% | 0.0% |
| Q3 2020 | $22,098,000 | -18.0% | 231,836 | -3.8% | 0.00% | -33.3% |
| Q2 2020 | $26,942,000 | +42.6% | 240,883 | -7.3% | 0.01% | +20.0% |
| Q1 2020 | $18,894,000 | -63.8% | 259,823 | -48.0% | 0.01% | 0.0% |
| Q4 2019 | $52,124,000 | +103.4% | 499,812 | +94.1% | 0.01% | -16.7% |
| Q3 2019 | $25,631,000 | -14.4% | 257,495 | -1.8% | 0.01% | -14.3% |
| Q2 2019 | $29,937,000 | -8.3% | 262,267 | +1.0% | 0.01% | -12.5% |
| Q1 2019 | $32,652,000 | -51.6% | 259,748 | -47.7% | 0.01% | -20.0% |
| Q4 2018 | $67,432,000 | +7.9% | 496,920 | +118.2% | 0.01% | -44.4% |
| Q3 2018 | $62,498,000 | +36.7% | 227,691 | +3.2% | 0.02% | +28.6% |
| Q2 2018 | $45,709,000 | +39.8% | 220,637 | +11.5% | 0.01% | +27.3% |
| Q1 2018 | $32,689,000 | +25.5% | 197,927 | +4.1% | 0.01% | +22.2% |
| Q4 2017 | $26,042,000 | +6.2% | 190,186 | +5.6% | 0.01% | 0.0% |
| Q3 2017 | $24,531,000 | +13.4% | 180,180 | +1.1% | 0.01% | 0.0% |
| Q2 2017 | $21,640,000 | +26.8% | 178,258 | +10.6% | 0.01% | +28.6% |
| Q1 2017 | $17,063,000 | +8.7% | 161,223 | +4.4% | 0.01% | 0.0% |
| Q4 2016 | $15,697,000 | +2.9% | 154,483 | +3.3% | 0.01% | -12.5% |
| Q3 2016 | $15,261,000 | -12.3% | 149,538 | +2.5% | 0.01% | -11.1% |
| Q2 2016 | $17,395,000 | +23.4% | 145,850 | +10.8% | 0.01% | +28.6% |
| Q1 2016 | $14,095,000 | +0.8% | 131,624 | +2.1% | 0.01% | -12.5% |
| Q4 2015 | $13,983,000 | +30.2% | 128,971 | +2.9% | 0.01% | +14.3% |
| Q3 2015 | $10,739,000 | -14.9% | 125,383 | +0.3% | 0.01% | 0.0% |
| Q2 2015 | $12,614,000 | +39.8% | 125,027 | +6.9% | 0.01% | +40.0% |
| Q1 2015 | $9,021,000 | +46.9% | 117,009 | +1.4% | 0.01% | +25.0% |
| Q4 2014 | $6,140,000 | +2.7% | 115,414 | -9.3% | 0.00% | 0.0% |
| Q3 2014 | $5,979,000 | -16.7% | 127,249 | +10.4% | 0.00% | -20.0% |
| Q2 2014 | $7,179,000 | -14.0% | 115,269 | -7.2% | 0.01% | -16.7% |
| Q1 2014 | $8,352,000 | +58.7% | 124,185 | +24.1% | 0.01% | +50.0% |
| Q4 2013 | $5,262,000 | +29.8% | 100,057 | +6.8% | 0.00% | +33.3% |
| Q3 2013 | $4,055,000 | +22.3% | 93,696 | +5.8% | 0.00% | 0.0% |
| Q2 2013 | $3,315,000 | – | 88,596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |